Total Payments
$24,438
2024 Payments
$37.98
Companies
19
Transactions
89
Medicare Patients
16,302
Medicare Billing
$2.6M
Payment Breakdown by Category
Other$20,000 (81.8%)
Food & Beverage$2,395 (9.8%)
Travel$1,882 (7.7%)
Education$160.47 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $20,000 | 2 | 81.8% |
| Food and Beverage | $2,395 | 78 | 9.8% |
| Travel and Lodging | $1,882 | 8 | 7.7% |
| Education | $160.47 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $20,166 | 5 | $0 (2018) |
| Nevro Corp. | $1,974 | 34 | $0 (2024) |
| Vertos Medical, Inc. | $1,047 | 8 | $0 (2019) |
| Abbott Laboratories | $470.61 | 5 | $0 (2023) |
| Boston Scientific Corporation | $328.90 | 14 | $0 (2023) |
| ABBVIE INC. | $61.14 | 3 | $0 (2022) |
| PFIZER INC. | $56.16 | 3 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $48.71 | 3 | $0 (2022) |
| SI-BONE, Inc. | $41.46 | 2 | $0 (2022) |
| Merz Pharmaceuticals, LLC | $40.10 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.98 | 2 | Nevro Corp. ($37.98) |
| 2023 | $168.99 | 9 | Nevro Corp. ($61.88) |
| 2022 | $127.36 | 7 | Biohaven Pharmaceutical Holding Company Ltd. ($48.71) |
| 2021 | $128.64 | 6 | BOSTON SCIENTIFIC CORPORATION ($39.76) |
| 2020 | $58.56 | 4 | Nevro Corp. ($44.10) |
| 2019 | $443.61 | 26 | Nevro Corp. ($133.81) |
| 2018 | $6,495 | 18 | Medtronic USA, Inc. ($5,166) |
| 2017 | $16,978 | 17 | Medtronic USA, Inc. ($15,000) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/29/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $40.10 | General |
| Category: Musculoskeletal | ||||||
| 08/16/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: PAIN | ||||||
| 08/07/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/27/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/22/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/26/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Neuromodulation | ||||||
| 04/24/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/20/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/08/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/12/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Bone Health | ||||||
| 11/29/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| 06/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PRIMARY CARE | ||||||
| 04/20/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: PRIMARY CARE | ||||||
| 02/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: PRIMARY CARE | ||||||
| 01/06/2022 | BOSTON SCIENTIFIC CORPORATION | GENERAL - THERAPIES (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: THERAPIES | ||||||
| 12/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: THERAPIES | ||||||
| 10/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2021 | BOSTON SCIENTIFIC CORPORATION | Superion (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/21/2021 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: Pain Management | ||||||
| 03/25/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: PRIMARY CARE | ||||||
| 06/17/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 4,245 | 7,309 | $3.1M | $712,032 |
| 2022 | 42 | 4,342 | 7,698 | $2.8M | $678,747 |
| 2021 | 43 | 4,349 | 8,308 | $2.7M | $707,863 |
| 2020 | 44 | 3,366 | 7,186 | $2.1M | $511,080 |
Total Patients
16,302
Total Services
30,501
Medicare Billing
$2.6M
Procedure Codes
174
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 189 | 205 | $467,883 | $105,995 | 22.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 263 | 416 | $371,884 | $82,431 | 22.2% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 180 | 301 | $256,406 | $60,297 | 23.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 187 | 204 | $259,875 | $59,648 | 23.0% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 103 | 114 | $219,234 | $53,278 | 24.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 191 | 213 | $152,721 | $43,729 | 28.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 258 | 409 | $182,007 | $43,061 | 23.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 176 | 200 | $194,811 | $32,909 | 16.9% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 96 | 106 | $122,025 | $30,129 | 24.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 174 | 288 | $122,980 | $29,869 | 24.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 122 | 141 | $102,366 | $29,054 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 224 | 224 | $97,216 | $26,993 | 27.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 65 | 71 | $61,152 | $15,778 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 168 | $56,379 | $15,434 | 27.4% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Office | 2023 | 24 | 31 | $44,170 | $12,546 | 28.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 98 | 131 | $41,658 | $12,400 | 29.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 94 | 142 | $30,690 | $6,617 | 21.6% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 56 | 56 | $71,512 | $6,083 | 8.5% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 13 | 17 | $18,224 | $5,507 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 83 | $19,671 | $5,288 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $14,550 | $4,267 | 29.3% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 18 | 20 | $15,250 | $3,681 | 24.1% |
| 64451 | Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | Office | 2023 | 15 | 18 | $20,096 | $3,663 | 18.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 14 | 15 | $33,852 | $3,254 | 9.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $10,314 | $2,851 | 27.6% |
About Dr. Forrest Monroe, MD
Dr. Forrest Monroe, MD is a Pain Medicine healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2013. The National Provider Identifier (NPI) number assigned to this provider is 1114362019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Forrest Monroe, MD has received a total of $24,438 in payments from pharmaceutical and medical device companies, with $37.98 received in 2024. These payments were reported across 89 transactions from 19 companies. The most common payment nature is "Grant" ($20,000).
As a Medicare-enrolled provider, Monroe has provided services to 16,302 Medicare beneficiaries, totaling 30,501 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Redding, CA
- Active Since 05/06/2013
- Last Updated 08/09/2018
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1114362019
Products in Payments
- ADAPTIVESTIM (Device) $20,000
- Senza Spinal Cord Stimulation System (Device) $1,874
- mild Device Kit (Device) $1,047
- SPECTRA WAVEWRITER (Device) $169.04
- Spinal Cord Stimulation Accessories (Device) $160.47
- RESTORE (Device) $142.27
- SCS IPGs (Device) $142.24
- Proclaim Family of SCS IPGs (Device) $113.83
- Senza (Device) $99.86
- NURTEC ODT (Drug) $83.64
- UBRELVY (Drug) $61.14
- GENERAL - PAIN MANAGEMENT (Device) $48.55
- Xeomin (Biological) $40.10
- LYRICA (Drug) $39.89
- EVENITY (Biological) $38.11
- Neuromodulation Dspsbls and Accs (Device) $35.58
- Nalu Neurostimulation System (Device) $31.45
- MYSTIM (Device) $23.66
- Superion (Device) $22.83
- iFuse Implant (Device) $22.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.